Field
     Health Care, Medicine, Experimental Cell
Keywords
     Breast Cancer, High Metastatic Potential, High Invasive Capacity


Abstracts
The object is to produce a model which acquires a high metastatic capability and a high invasive capability of a cell related to breast cancer. Specifically disclosed is a MCF7-derived cell which is derived from a MCF7 cell and has a significantly higher invasive capability or metastatic capability compared to a MCF7 cell. The MCF7-derived cell can be produced by collecting a MCF7 cell that acquires a capability of passing through a basement membrane preparation such as Matrigel or an analogue thereof.


Inventor
    Prof. Yasufumi Murakami  (Tokyo University of Science)


Patent Publication No
(APPLICATION NUMBER, FILING DATE)
WO2008051979 (Jan. 30, 2008), JP2008-556219 (Jan. 30, 2008)
(PUBLICATION NUMBER, PUBLICATION DATE)
WO2008/093886A1 (Aug. 7, 2007)
(PRIORITY APPLICATION NUMBER, PRIORITY DATE)JP2007-020101 (Jan. 30, 2007)


Internal file number
G2007-009, T2009-024, (T2006-107)

To access the rest of the information on this page,
Log In or sign up for a free B-Bridge account: